Paid Clinical Trials and Focus Groups by Location |
|
|
|
Conditions: Obesity; Bariatric Surgery; Morbid Obesity; Diabetes Mellitus Type 2; Diet Therapy
Interventions: Procedure: Roux-en-Y Gastric Bypass; Behavioral: Caloric Restriction
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified February 2010
Conditions: Wounds and Injuries; Wound Healing; Ulcer
Intervention:
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR)
Recruiting - verified November 2009
Conditions: Cancer; Pain
Intervention:
Sponsor: National Institutes of Health Clinical Center (CC)
Recruiting - verified August 2009
Condition: Parkinson Disease
Intervention:
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified December 2009
Conditions: Bone Marrow; Bone Marrow Stromal Cells; Mesenchymal Stem Cells; Blood Donors
Intervention:
Sponsor: National Institutes of Health Clinical Center (CC)
Recruiting - verified January 2010
Condition: Mitral Valve Regurgitation
Intervention:
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified December 2009
Condition: Perennial Allergic Rhinitis
Intervention: Drug: ciclesonide HFA 160 μg
Sponsor: Sepracor, Inc.
Recruiting - verified February 2010
Conditions: Chronic Granulomatous Disease (CGD); Atherosclerosis; Immune Deficiencies; Inflammatory Bowel Disease
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified November 2009
Condition: Schizophrenia
Intervention:
Sponsor: National Institute of Mental Health (NIMH)
Recruiting - verified January 2010
Conditions: Acute Myocardial Infarction; Coronary Artery Disease; Myocardial Fibrosis; Gadolinium; Myocardial Edema
Intervention:
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified December 2009
Condition: Myelodysplastic Syndrome
Interventions: Drug: Ezatiostat Hydrochloride; Drug: Lenalidomide (Revlimid®)
Sponsor: Telik
Recruiting - verified February 2010
Condition: Hairy Cell Leukemia
Interventions: Drug: Pentostatin; Drug: Rituximab; Drug: Bendamustine
Sponsor: National Cancer Institute (NCI)
Recruiting - verified November 2009
Condition: Anxiety Disorders
Intervention:
Sponsor: National Institute of Mental Health (NIMH)
Recruiting - verified December 2009
Condition: Autism Spectrum Disorder
Intervention:
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified November 2009
Conditions: Non-small Cell Lung Cancer; Adenocarcinoma
Interventions: Drug: SS1 (dsFv) PE38; Drug: Paclitaxel; Drug: Carboplatin; Drug: Bevacizumab
Sponsor: National Cancer Institute (NCI)
Recruiting - verified December 2009
Conditions: Neoplasms; Lymphoma
Interventions: Drug: LMP 400; Drug: LMP 776
Sponsor: National Cancer Institute (NCI)
Recruiting - verified July 2009
Condition: Partial Epilepsy
Intervention: Drug: VX-765
Sponsor: Vertex Pharmaceuticals Incorporated
Recruiting - verified February 2010
Condition: Movement Disorder
Intervention:
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified October 2009
Conditions: Hodgkin Lymphoma; Diffuse Large B-cell Lymphoma
Interventions: Drug: Cylcophosphamide; Drug: Etoposide; Drug: Alemtuzumab; Drug: Doxorubicin; Drug: Prednisone; Drug: Filgrastim; Drug: Rituximab; Drug: Vincristine
Sponsor: National Cancer Institute (NCI)
Recruiting - verified September 2009
Condition: Extensive-Stage Small Cell Lung Cancer
Interventions: Drug: Amrubicin; Drug: Carboplatin; Drug: Pegfilgrastim
Sponsors: Sarah Cannon Research Institute; Celgene Corporation
Recruiting - verified March 2010
Conditions: Childhood Obsessive-Compulsive Disorder; Autism Spectrum Disorders
Intervention:
Sponsor: National Institute of Mental Health (NIMH)
Recruiting - verified November 2009
Conditions: Back Pain; Chronic Low Back Pain; Internal Disc Disruption; Degenerative Disc Disease
Interventions: Biological: Biostat System; Drug: Sodium Chloride Injection
Sponsor: Spinal Restoration, Inc.
Recruiting - verified March 2010
Condition: Myelodysplastic Syndromes
Interventions: Drug: decitabine; Drug: azacitidine
Sponsor: Eisai Inc.
Not yet recruiting - verified February 2010
Condition: Asthma
Interventions: Drug: Fluticasone Furoate/GW642444; Drug: Fluticasone propionate
Sponsor: GlaxoSmithKline
Recruiting - verified February 2010
Condition: Plasmodium Falciparum
Intervention: Biological: Plasmodium falciparum Sporozoite (strain NF-54; Anopheles stephensi mosquitoes) Vaccine, Live, Inactivated (gamma irradiation)
Sponsors: Sanaria Inc.; The PATH Malaria Vaccine Initiative (MVI)
Recruiting - verified March 2010
Condition: Sickle Cell Disease
Interventions: Other: High Demand / Low Infusion; Other: PCA Dosing Plan
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified February 2010
Conditions: Low Bone Mass; Low Bone Mineral Density; Males With Osteoporosis; Osteopenia; Osteoporosis
Interventions: Drug: 60 mg denosumab; Other: Placebo
Sponsor: Amgen
Recruiting - verified February 2010
Conditions: Leukemia; Non-Hodgkins Lymphoma; Hodgkins Lymphoma; MDS; Multiple Myeloma
Interventions: Drug: EPOCH-F/R; Drug: FLAG; Drug: Transplant Preparative Regimen (Flu/Cy/Mes); Drug: GVHD Prophylaxis (tacrolimus and sirolimus); Procedure: Double Cord Blood Transplantation
Sponsor: National Cancer Institute (NCI)
Recruiting - verified November 2009
Conditions: HIV; Asthma
Interventions: Drug: Darunavir; Drug: Ritonavir; Drug: Beclomethasone Dipropionate HFA
Sponsor: National Institutes of Health Clinical Center (CC)
Recruiting - verified July 2009
Condition: Postmenopausal Osteoporosis
Interventions: Drug: Ibandronate; Drug: Denosumab
Sponsor: Amgen
Recruiting - verified March 2010
Conditions: Epilepsy; Epilepsy, Temporal Lobe; Depression; Depressive Disorder, Major
Intervention:
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified February 2010
Condition: Osteoporosis, Post-Menopausal
Interventions: Drug: Teriparatide; Drug: Zoledronic Acid
Sponsor: Eli Lilly and Company
Recruiting - verified February 2010
Conditions: Autologous Stem Cell Transplantation; Allogeneic Stem Cell Transplantation; Solid Tumors; Blood Cancers
Intervention:
Sponsor: National Cancer Institute (NCI)
Recruiting - verified November 2009
Condition: Sarcoma, Kaposi
Interventions: Drug: Liposomal Doxorubicin; Drug: Bevacizumab
Sponsor: National Cancer Institute (NCI)
Recruiting - verified March 2010
Condition: Hairy Cell Leukemia
Intervention: Drug: BL22 (CAT-3888)
Sponsor: National Cancer Institute (NCI)
Recruiting - verified November 2009
Conditions: Glioblastoma Multiforme; Malignant Gliomas; Anaplastic Gliomas
Intervention: Drug: Sutent (sunitinib)
Sponsor: National Cancer Institute (NCI)
Recruiting - verified February 2010
Conditions: Melanoma; Skin Cancer
Interventions: Drug: MART-1: 26-35(27L) Peptide; Drug: Montanide ISA 51 VG; Drug: gp100:154-162 Peptide; Drug: PG 13/Faf2aB C 162D1 (anti- MART-1 F5 TCR); Drug: PG13-154-Ecll AIB (anti-gp100:154-162 TCR); Procedure: Radiation; Drug: Aldesleukin; Drug: Fludarabine; Drug: Cyclophosphamide; Genetic: Anti-gp 100:154 TCR PBL; Genetic: Anti-MART-1 F5 TCR PBL
Sponsor: National Cancer Institute (NCI)
Recruiting - verified February 2010
Conditions: Breast Cancer; Healthy Volunteer
Intervention:
Sponsor: National Cancer Institute (NCI)
Recruiting - verified April 2009
Conditions: Neuroblastoma; Sarcoma; Rhabdomyosarcoma-Embryonal; Rhabdomyosarcoma- Alveolar; Neuroectodermal Tumors, Primitive, Peripheral
Interventions: Drug: Tumor Purged/CD25 Depleted Lymphocytes; Biological: Tumor Purged/CD25 Depleted Lymphocytes with Tumor Lysate/KLH Pulsed Dendritic Cell Vaccine; Drug: IL-4; Device: Miltenyi CliniMACS-System; Drug: Tumor Lysate/KLH Pulsed Dendritic Cell Vaccine; Drug: KLH; Drug: MAB 8H9; Drug: Endotoxin
Sponsor: National Cancer Institute (NCI)
Recruiting - verified February 2010
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: FDG-PET; Drug: Pemetrexed; Drug: Sirolimus
Sponsor: National Cancer Institute (NCI)
Recruiting - verified July 2009
Conditions: Cancer; Colon Cancer; Colorectal Cancer; Fever; Locally Advanced; Metastatic Colorectal Cancer; Neutropenia; Rectal Cancer
Interventions: Drug: Pegfilgrastim; Drug: Placebo
Sponsor: Amgen
Recruiting - verified March 2010
Conditions: Movement Disorders; Heathly Subjects
Intervention:
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified February 2010
Conditions: Lymphohistiocytosis, Hemophagocytic; Common Variable Immunodeficiency; Severe Combined Immunodeficiency
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Conditions: Acute Ischemic Stroke; Stroke; Brain Infarction
Interventions: Drug: Eptifibatide; Drug: rt-PA
Sponsors: University of Cincinnati; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified February 2010
Conditions: Leukodystrophy; Leukoencephalopathy
Intervention:
Sponsor: National Human Genome Research Institute (NHGRI)
Recruiting - verified February 2010
Conditions: Healthy Volunteer; Fatigue; Depression
Intervention:
Sponsor: National Institute of Nursing Research (NINR)
Recruiting - verified February 2010
Conditions: Autoinflammatory Syndromes; Physical Urticaria
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Condition: Breast Cancer
Interventions: Drug: bevacizumab; Drug: docetaxel; Drug: doxorubicin; Drug: cyclophosphamide; Drug: cyclophosphamide; Drug: pegfilgrastim
Sponsors: National Surgical Adjuvant Breast and Bowel Project (NSABP); Genentech; US Oncology Research
Recruiting - verified March 2010
Condition: Healthy
Intervention:
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified March 2010
Conditions: Coronary Artery Bypass; Myocardial Infarction; Ventricular Dysfunction, Left; Stroke; Cardiopulmonary Bypass
Interventions: Drug: Acadesine; Drug: Normal Saline
Sponsor: Schering-Plough
Recruiting - verified March 2010
Condition: Epilepsy With Simple or Complex Partial Onset Seizures
Interventions: Drug: Eslicarbazepine acetate; Drug: Eslicarbazepine acetate
Sponsor: Sepracor, Inc.
Recruiting - verified February 2010
Conditions: Cocaine Addiction; Cocaine Abuse
Intervention:
Sponsor: National Institute on Drug Abuse (NIDA)
Not yet recruiting - verified January 2010
Condition: Breast Cancer
Interventions: Drug: Everolimus, Exemestane; Drug: Placebo, Exemestane
Sponsor: Novartis Pharmaceuticals
Recruiting - verified March 2010
Condition: Diabetes Mellitus Type II Non Insulin Dependent
Interventions: Dietary Supplement: Vitamin E; Dietary Supplement: Vitamin C; Dietary Supplement: Lipid Oxidation
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified January 2010
Conditions: Non-small Cell Lung Cancer; Anemia; Cancer; Lung Cancer
Interventions: Drug: darbepoetin alfa 500 mcg Q3W; Drug: placebo
Sponsor: Amgen
Recruiting - verified March 2010
Conditions: Cancer; Fatigue
Intervention:
Sponsor: National Institute of Nursing Research (NINR)
Recruiting - verified December 2009
Conditions: B-Cell Lymphoma; B-Cell Leukemia
Intervention: Drug: PCI-32765
Sponsor: Pharmacyclics
Recruiting - verified July 2009
Condition: Metastatic Pancreatic Cancer
Interventions: Drug: ABI-007/Gemcitabine; Drug: Gemcitabine
Sponsor: Abraxis BioScience Inc.
Recruiting - verified December 2009
Condition: Carcinoma, Non-small Cell
Intervention: Drug: PF-00299804
Sponsor: Pfizer
Recruiting - verified March 2010
Conditions: Leukemia; Lymphoma; Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: ABT-888; Drug: cyclophosphamide; Other: immunologic technique; Other: laboratory biomarker analysis; Other: liquid chromatography; Other: mass spectrometry; Other: pharmacological study
Sponsor: National Cancer Institute (NCI)
Recruiting - verified February 2010
Conditions: Acute Coronary Syndrome; Myocardial Infarction; Myocardial Ischemia; Unstable Angina
Intervention: Drug: Rivaroxaban; Placebo
Sponsors: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Bayer
Recruiting - verified February 2010
Conditions: Colon Cancer; Colorectal Cancer; Rectal Cancer; Metastatic Colorectal Cancer
Interventions: Drug: Panitumumab; Drug: Bevacizumab; Drug: mFOLFOX6
Sponsor: Amgen
Recruiting - verified March 2010
Conditions: Rhinitis; Allergic Conjunctivitis
Interventions: Biological: 6 Amb a 1-U; Biological: 12 Amb a 1-U; Biological: Placebo
Sponsor: Schering-Plough
Recruiting - verified March 2010
Conditions: NOMID; CINCA Syndrome
Interventions: Drug: Canakinumab; Drug: ACZ885
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified September 2009
Conditions: Cognitive/Functional Effects; Metastatic Cancer; Psychosocial Effects of Cancer and Its Treatment; Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Other: immunoenzyme technique; Other: laboratory biomarker analysis; Other: questionnaire administration; Procedure: assessment of therapy complications; Procedure: cognitive assessment; Procedure: psychosocial assessment and care; Radiation: radiation therapy; Radiation: stereotactic radiosurgery
Sponsor: National Cancer Institute (NCI)
Recruiting - verified December 2008
Condition: Non-small Cell Lung Cancer
Interventions: Drug: Erlotinib; Drug: PF-00299804
Sponsor: Pfizer
Recruiting - verified March 2010
Conditions: Distress; Hematopoietic Stem Cell Transplantation
Intervention: Behavioral: Problem Solving Education
Sponsor: National Institutes of Health Clinical Center (CC)
Recruiting - verified August 2009
Condition: Non-small Cell Lung Cancer
Interventions: Drug: Pemetrexed; Drug: Pemetrexed; Drug: Paclitaxel; Drug: Carboplatin; Biological: Bevacizumab; Biological: Bevacizumab
Sponsor: Eli Lilly and Company
Recruiting - verified February 2010
Condition: Osteosarcoma
Interventions: Drug: AZD0530; Drug: Placebo
Sponsors: Sarcoma Alliance for Research through Collaboration; AstraZeneca
Recruiting - verified February 2010
Condition: Malignant Pleural Mesothelioma
Intervention: Drug: MORAb-009 by IV on Days 1 and 8 every 21 days for 6 cycles.
Sponsor: Morphotek
Recruiting - verified March 2010
Conditions: Brain and Central Nervous System Tumors; Cognitive/Functional Effects
Interventions: Drug: temozolomide; Drug: vorinostat; Procedure: adjuvant therapy; Procedure: cognitive assessment; Radiation: radiation therapy
Sponsors: North Central Cancer Treatment Group; National Cancer Institute (NCI)
Recruiting - verified January 2010
Condition: Ovarian Cancer
Interventions: Drug: EC145; Drug: pegylated liposomal doxorubicin (PLD); Drug: EC20; Drug: EC20
Sponsor: Endocyte
Recruiting - verified February 2010
Condition: Hepatitis C, Chronic
Interventions: Procedure: Liver Biopsy; Drug: Peginterferon & Ribavirin for Hepatitis C; Drug: Pre-treatment Ribavirin
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified May 2009
Condition: Alcoholic Intoxication
Interventions: Drug: Alcohol; Procedure: Self-Administration
Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Recruiting - verified May 2009
Condition: Diabetic Retinopathy
Interventions: Drug: Sirolimus; Drug: Rapamycin
Sponsor: National Eye Institute (NEI)
Recruiting - verified March 2009
Conditions: Metastatic Breast Cancer; First or Second Line Therapy
Intervention: Drug: Lapatinib, Vinorelbine
Sponsor: GlaxoSmithKline
Recruiting - verified February 2010
Condition: Non Small Cell Lung Cancer
Interventions: Drug: Talactoferrin; Drug: Placebo
Sponsor: Agennix
Recruiting - verified March 2010
Condition: Obesity
Interventions: Drug: Sincalide; Drug: Ursodiol Acid; Procedure: High Fat/Low Fat Diet
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified February 2010
Condition: HIV Infections
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2009
Condition: Cancer
Interventions: Drug: imatinib mesylate; Genetic: reverse transcriptase-polymerase chain reaction; Other: confocal microscopy; Other: flow cytometry; Other: immunoenzyme technique; Other: immunohistochemistry staining method; Other: laboratory biomarker analysis; Other: pharmacological study; Procedure: allogeneic hematopoietic stem cell transplantation; Procedure: biopsy
Sponsor: National Cancer Institute (NCI)
Recruiting - verified February 2010
Condition: Alcohol Drinking
Interventions: Drug: Varenicline; Drug: Varenicline (Chantix)
Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Recruiting - verified January 2010
Conditions: Breast Cancer; Osteoporosis
Interventions: Drug: exemestane; Other: biologic sample preservation procedure; Other: physiologic testing; Procedure: dual x-ray absorptometry
Sponsor: NCIC Clinical Trials Group
Recruiting - verified June 2009
Condition: Non Small Cell Lung Cancer
Interventions: Drug: Pemetrexed; Drug: Cisplatin; Drug: Etoposide; Drug: Cisplatin; Drug: Vinorelbine; Drug: Paclitaxel; Drug: Carboplatin; Radiation: Thoracic Radiation Therapy (TRT); Radiation: Thoracic Radiation Therapy (TRT)
Sponsor: Eli Lilly and Company
Recruiting - verified February 2010
Condition: Breast Cancer
Interventions: Biological: cixutumumab; Drug: capecitabine; Drug: lapatinib ditosylate
Sponsors: North Central Cancer Treatment Group; National Cancer Institute (NCI); Southwest Oncology Group
Recruiting - verified March 2010
Conditions: Prevention of Venous Thromboembolism; Cancer
Interventions: Drug: AVE5026; Drug: Placebo
Sponsor: Sanofi-Aventis
Recruiting - verified February 2010
Conditions: Lymphoma; Lymphoproliferative Disorder; Small Intestine Cancer; Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: pazopanib hydrochloride; Other: pharmacological study
Sponsors: Beckman Research Institute; National Cancer Institute (NCI)
Recruiting - verified January 2010
Conditions: Atherosclerosis; Diabetes Mellitus; Obesity; Dyslipidemia; Hypertension
Interventions: Behavioral: Exercise; Behavioral: Weight Loss
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified January 2010
Condition: Melanoma (Skin)
Intervention: Biological: aldesleukin
Sponsor: National Cancer Institute (NCI)
Recruiting - verified July 2009
Conditions: Breast Cancer; Cognitive/Functional Effects; Fatigue; Psychosocial Effects of Cancer and Its Treatment; Sleep Disorders
Interventions: Procedure: assessment of therapy complications; Procedure: cognitive assessment; Procedure: fatigue assessment and management; Procedure: psychosocial assessment and care
Sponsors: International Breast Cancer Study Group; National Cancer Institute (NCI); Australian New Zealand Breast Cancer Trials Group; Cancer and Leukemia Group B
Recruiting - verified March 2010
Condition: Cancer
Interventions: Drug: montelukast sodium; Other: flow cytometry; Other: laboratory biomarker analysis; Procedure: quality-of-life assessment
Sponsor: National Cancer Institute (NCI)
Recruiting - verified August 2008
Conditions: Solid Tumor Malignancy; Lymphoid Malignancy (Lymphoma and CLL); Leukemia; Lymphoma
Intervention: Drug: SNX-5422 Mesylate Hsp90 inhibitor
Sponsors: Pfizer; National Cancer Institute (NCI)
Recruiting - verified February 2010
Conditions: Leukemia; Lymphoma; Lymphoproliferative Disorder; Small Intestine Cancer; Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: Hsp90 inhibitor SNX-5422 mesylate; Other: flow cytometry; Other: high performance liquid chromatography; Other: mass spectrometry; Other: pharmacological study
Sponsor: National Cancer Institute (NCI)
Recruiting - verified July 2009
Condition: Unspecified Childhood Solid Tumor, Protocol Specific
Intervention: Biological: aflibercept
Sponsors: Children's Oncology Group; National Cancer Institute (NCI)
Recruiting - verified March 2010
Condition: Melanoma (Skin)
Interventions: Biological: ALVAC-CEA vaccine; Biological: aldesleukin; Biological: autologous anti-gp100:154-162 T-cell receptor gene-engineered peripheral blood lymphocytes; Drug: cyclophosphamide; Drug: fludarabine phosphate
Sponsor: National Cancer Institute (NCI)
Recruiting - verified October 2008
Conditions: Barrett's Esophagus; Esophageal Neoplasms
Intervention:
Sponsors: Kansas City Veteran Affairs Medical Center; TAP Pharmaceutical Products Inc.
Recruiting - verified February 2010
Condition: Metastatic Breast Cancer
Interventions: Drug: docetaxel; Drug: pertuzumab; Drug: placebo; Drug: trastuzumab
Sponsors: Genentech; Roche Pharma AG
Recruiting - verified February 2010
Condition: Inflammatory Disorder
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2009
Conditions: Lymphoma; Lymphoproliferative Disorder; Sarcoma; Small Intestine Cancer; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Other: biologic sample preservation procedure; Other: cytology specimen collection procedure; Other: immunologic technique; Procedure: biopsy; Procedure: study of high risk factors
Sponsor: National Cancer Institute (NCI)
Recruiting - verified August 2009
Condition: Carcinoma, Non Small Cell Lung
Interventions: Drug: PF-00299804; Drug: PF-00299804
Sponsor: Pfizer
Recruiting - verified March 2010
Conditions: Prostate Cancer; Breast Cancer; Ovarian Cancer; Lung Cancer; Gastric Cancer
Intervention: Drug: Docetaxel plus lonafarnib
Sponsor: Schering-Plough
Recruiting - verified March 2010
Condition: Epilepsy
Interventions: Drug: lacosamide; Drug: lacosamide
Sponsor: UCB, Inc.
Recruiting - verified March 2010
Conditions: Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes
Interventions: Biological: alemtuzumab; Biological: rituximab; Drug: cyclophosphamide; Drug: cyclosporine; Drug: cytarabine; Drug: doxorubicin hydrochloride; Drug: etoposide; Drug: fludarabine phosphate; Drug: methotrexate; Drug: prednisone; Drug: sirolimus; Drug: tacrolimus; Drug: vincristine sulfate
Sponsor: National Cancer Institute (NCI)
Recruiting - verified July 2009
Condition: Multiple Myeloma
Interventions: Drug: bortezomib, thalidomide, and dexamethasone (VTD); Drug: bortezomib and dexamethasone (VD); Drug: bortezomib, melphalan and prednisone (VMP)
Sponsor: Millennium Pharmaceuticals, Inc.
Recruiting - verified February 2010
Condition: Chronic Idiopathic Thrombocytopenic Purpura
Interventions: Biological: Gammaplex, intravenous immunoglobulin; Biological: Gammaplex; Biological: Gammaplex
Sponsor: Bio Products Laboratory
Recruiting - verified March 2010
Conditions: Lymphoma; Small Intestine Cancer; Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: vorinostat; Other: pharmacological study
Sponsors: University of Pittsburgh; National Cancer Institute (NCI)
Recruiting - verified July 2009
Conditions: Chuvash Polycythemia; Cerebrovascular Disease; Pulmonary Hypertension; Sickle Cell Anemia
Intervention:
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified March 2009
Conditions: Congenital Heart Disease; Atherosclerosis; Myocardial Ischemia; Myocardial Infarction; Acquired Heart Disease
Intervention:
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified February 2010
Condition: Renal Cell Carcinoma
Interventions: Drug: Temsirolimus; Drug: Sorafenib
Sponsor: Wyeth
Recruiting - verified February 2010
Conditions: Lymphoma; Small Intestine Cancer; Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: daniquidone; Other: pharmacological study
Sponsor: National Cancer Institute (NCI)
Recruiting - verified June 2009
Condition: Cancer
Interventions: Other: counseling intervention; Other: educational intervention; Procedure: psychosocial assessment and care
Sponsor: National Cancer Institute (NCI)
Recruiting - verified December 2008
Condition: Breast Cancer
Interventions: Biological: bevacizumab; Drug: cyclophosphamide; Drug: paclitaxel; Drug: pegylated liposomal doxorubicin hydrochloride; Other: placebo
Sponsors: Eastern Cooperative Oncology Group; National Cancer Institute (NCI); North Central Cancer Treatment Group; Cancer and Leukemia Group B
Recruiting - verified March 2010
Conditions: Morbid Obesity; Diabetes Mellitus Type 2; Insulin Resistance; Obstructive Sleep Apnea; Mood Disorders
Intervention:
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified July 2009
Conditions: MUD Transplant; AlloPBSC; Congenital Immunodeficiencies; HLA Matched Transplant; BMT
Interventions: Drug: Busulfan; Drug: Campath-1 H; Drug: Sirolimus; Procedure: BMT; Procedure: Apheresis; Procedure: Total Body Irradiation; Procedure: GCSF Injections
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified June 2009
Conditions: Cancer; Colon Cancer; Colorectal Cancer; Metastatic Cancer; Rectal Cancer; Metastatic Colorectal Cancer
Interventions: Drug: FOLFIRI - Panitumumab; Drug: FOLFIRI - Bevacizumab
Sponsor: Amgen
Recruiting - verified February 2010
Conditions: Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Secondary Myelofibrosis; Small Intestine Cancer
Interventions: Biological: therapeutic allogeneic lymphocytes; Drug: cyclophosphamide; Drug: cyclosporine; Drug: fludarabine phosphate; Drug: tacrolimus; Procedure: allogeneic hematopoietic stem cell transplantation; Procedure: in vitro-treated peripheral blood stem cell transplantation; Procedure: peripheral blood stem cell transplantation; Radiation: total-body irradiation
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified June 2009
Condition: Metabolism
Intervention:
Sponsor: National Human Genome Research Institute (NHGRI)
Recruiting - verified January 2010
Conditions: Mycobacteria, Atypical; Cystic Fibrosis; Ciliary Disorders; Pseudohypoaldosteronism; Bronchiectasis
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified January 2010
Condition: Fragile X Syndrome
Intervention:
Sponsor: National Institute of Mental Health (NIMH)
Recruiting - verified March 2009
Condition: Southern Tick-Associated Rash Illness
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Conditions: Leukemia; Unspecified Childhood Solid Tumor, Protocol Specific
Intervention: Drug: sorafenib tosylate
Sponsors: Children's Oncology Group; National Cancer Institute (NCI)
Recruiting - verified March 2010
Condition: Pneumocystis Pneumonia
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Conditions: Obesity; Adipose Cell Turn Over
Intervention:
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified February 2010
Condition: Genetic Variation
Intervention:
Sponsor: National Human Genome Research Institute (NHGRI)
Recruiting - verified April 2009
Condition: Cancer
Interventions: Other: laboratory biomarker analysis; Other: physiologic testing; Procedure: biopsy; Procedure: management of therapy complications
Sponsor: National Cancer Institute (NCI)
Recruiting - verified September 2006
Condition: Kidney Cancer
Interventions: Drug: sorafenib tosylate; Drug: sunitinib malate; Other: placebo
Sponsors: Eastern Cooperative Oncology Group; National Cancer Institute (NCI); Cancer and Leukemia Group B; Southwest Oncology Group; NCIC Clinical Trials Group
Recruiting - verified March 2010
Condition: Multiple Sclerosis
Intervention:
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified February 2010
Condition: Stem Cell Mobilization
Intervention: Drug: AMD3100
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified March 2010
Conditions: Epilepsy; Epilepsy, Generalized; Epilepsy, Complex Partial; Epilepsies, Partial; Seizures
Interventions: Drug: Diazepam; Drug: Placebo
Sponsor: King Pharmaceuticals Research and Development
Recruiting - verified March 2010
Condition: Wisdom Teeth
Intervention:
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR)
Recruiting - verified March 2009
Condition: Movement Disorders
Intervention:
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified February 2010
Condition: Obesity
Intervention:
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified August 2009
Condition: Lymphoma
Interventions: Biological: filgrastim; Biological: rituximab; Drug: cyclophosphamide; Drug: doxorubicin hydrochloride; Drug: etoposide; Drug: prednisone; Drug: vincristine sulfate
Sponsors: Cancer and Leukemia Group B; National Cancer Institute (NCI)
Recruiting - verified March 2010
Conditions: Brain and Central Nervous System Tumors; Carcinoma of Unknown Primary; Leukemia; Lymphoma; Metastatic Cancer; Unspecified Childhood Solid Tumor, Protocol Specific
Intervention: Drug: topotecan hydrochloride
Sponsors: Pediatric Brain Tumor Consortium; National Cancer Institute (NCI)
Recruiting - verified April 2008
Condition: Healthy
Intervention: Procedure: Magnetic Resonance Spectroscopy
Sponsor: National Institute of Mental Health (NIMH)
Recruiting - verified December 2009
Conditions: Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm
Intervention: Drug: fenretinide
Sponsors: California Cancer Consortium; National Cancer Institute (NCI)
Recruiting - verified July 2009
Conditions: Attention Deficit Disorder With Hyperactivity; Mental Disorders Diagnosed in Childhood; Conduct Disorder
Intervention:
Sponsor: National Institute of Mental Health (NIMH)
Recruiting - verified January 2010
Condition: Hypersensitivity, Immediate
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified September 2009
Conditions: Hemoglobinopathies; Hemolysis; Iron Deficiency and Overload; Anemias
Intervention:
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified February 2010
Condition: Cancer
Interventions: Drug: isolated perfusion; Drug: melphalan
Sponsor: National Cancer Institute (NCI)
Recruiting - verified July 2009
Conditions: Depression; Major Depression/Bipolar Disorder
Interventions: Drug: Ketamine; Drug: Riluzole; Drug: FDG
Sponsor: National Institute of Mental Health (NIMH)
Recruiting - verified February 2010
Condition: Healthy
Intervention:
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified January 2010
Condition: Breast Cancer
Intervention: Drug: exemestane
Sponsor: NCIC Clinical Trials Group
Recruiting - verified March 2010
Conditions: Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
Interventions: Biological: filgrastim; Biological: graft-versus-tumor induction therapy; Biological: rituximab; Biological: therapeutic allogeneic lymphocytes; Drug: cyclophosphamide; Drug: cyclosporine; Drug: cytarabine; Drug: doxorubicin hydrochloride; Drug: etoposide; Drug: fludarabine phosphate; Drug: prednisone; Drug: vincristine sulfate; Procedure: peripheral blood stem cell transplantation
Sponsor: National Cancer Institute (NCI)
Recruiting - verified July 2009
Conditions: Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
Interventions: Biological: therapeutic allogeneic lymphocytes; Drug: sirolimus
Sponsor: National Cancer Institute (NCI)
Recruiting - verified November 2007
Condition: Diabetes Mellitus
Intervention:
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified January 2010
Conditions: Neoplasms; Hematologic Neoplasms
Intervention:
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified January 2010
Condition: Neoplasms
Intervention:
Sponsor: National Cancer Institute (NCI)
Recruiting - verified December 2009
Condition: Breast Cancer
Interventions: Drug: exemestane; Drug: tamoxifen citrate
Sponsors: International Breast Cancer Study Group; National Cancer Institute (NCI); Breast International Group
Recruiting - verified March 2010
Condition: Breast Cancer
Interventions: Drug: exemestane; Drug: tamoxifen citrate; Drug: triptorelin; Procedure: oophorectomy; Radiation: radiation therapy
Sponsors: International Breast Cancer Study Group; National Cancer Institute (NCI); Breast International Group; Cancer and Leukemia Group B; NCIC Clinical Trials Group; North Central Cancer Treatment Group; National Surgical Adjuvant Breast and Bowel Project (NSABP); Southwest Oncology Group
Recruiting - verified March 2010
Condition: Autonomic Nervous System Diseases
Intervention:
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified January 2010
Condition: Anxiety Disorders
Intervention:
Sponsor: National Institute of Mental Health (NIMH)
Recruiting - verified December 2009
Conditions: Leukemia; Lymphoma; Lymphoproliferative Disorder; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
Interventions: Genetic: genetic linkage analysis; Genetic: microarray analysis; Other: counseling intervention; Other: laboratory biomarker analysis; Other: questionnaire administration; Procedure: evaluation of cancer risk factors
Sponsor: National Cancer Institute (NCI)
Recruiting - verified April 2007
Conditions: Brain and Central Nervous System Tumors; Lymphoma
Interventions: Other: biologic sample preservation procedure; Other: diagnostic laboratory biomarker analysis; Other: physiologic testing; Procedure: diagnostic imaging
Sponsor: National Cancer Institute (NCI)
Recruiting - verified April 2008
Condition: HIV Infections
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified January 2010
Condition: Healthy
Intervention:
Sponsor: National Cancer Institute (NCI)
Recruiting - verified October 2009
Condition: Kaposi's Sarcoma
Intervention:
Sponsor: National Cancer Institute (NCI)
Recruiting - verified August 2009
Conditions: Mood Disorder; Anxiety Disorder
Intervention:
Sponsor: National Institute of Mental Health (NIMH)
Recruiting - verified November 2009
Condition: Immunologic Disease
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified July 2009
Conditions: Depression; Mood Disorder; Anxiety Disorder; Healthy
Intervention:
Sponsor: National Institute of Mental Health (NIMH)
Recruiting - verified April 2009
Conditions: Neurological Disorder; Muscle Cramp
Intervention:
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified February 2010
Conditions: Muscle Spasticity; Healthy
Intervention:
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified February 2010
Condition: Adrenal Gland Neoplasm
Intervention:
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified January 2010
Condition: Osteogenesis Imperfecta
Intervention: Drug: Pamidronate (Aredia)
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified February 2010
Condition: Diabetic Retinopathy
Intervention:
Sponsor: National Eye Institute (NEI)
Recruiting - verified September 2009
Conditions: Endocrine Disease; Glucose Intolerance; Hyperinsulinemia; Impaired Glucose Tolerance; Non Insulin Dependent Diabetes Mellitus; Obesity; Type II Diabetes Mellitus
Intervention:
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified February 2010
Condition: Hepatitis C
Intervention:
Sponsor: National Institutes of Health Clinical Center (CC)
Recruiting - verified February 2010
Conditions: Syringomyelia; Type I Arnold Chiari Malformation
Intervention:
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified January 2010
Condition: Healthy
Intervention:
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified January 2010
Conditions: Cystic Fibrosis; Sarcoidosis; Tuberous Sclerosis; Asthma
Intervention:
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified January 2010
Conditions: Psychotic Disorder; Schizophrenia; Schizoaffective; Paranoia; Psychosis
Intervention:
Sponsor: National Institute of Mental Health (NIMH)
Recruiting - verified August 2009
Conditions: Arnold Chiari Deformity; Hydrocephalus; Syringomyelia
Intervention:
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified June 2009
Conditions: Cardiovascular Disease; Hypertension; Non Insulin Dependent Diabetes Mellitus; Obesity
Intervention:
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified February 2010
Condition: Hypogonadism
Intervention:
Sponsor: National Institute of Mental Health (NIMH)
Recruiting - verified February 2010
Conditions: Graft vs Host Disease; Healthy; Lymphopenia
Intervention: Drug: G-CSF
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified December 2009
Conditions: Filariasis; Helminthiasis; Loiasis; Mansonelliasis; Onchocerciasis
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified March 2009
Conditions: Autoimmune Disease; Congenital Adrenal Hyperplasia; Healthy; Mental Disorder Diagnosed in Childhood; Neurologic Manifestations
Intervention:
Sponsor: National Institute of Mental Health (NIMH)
Recruiting - verified November 2009
Conditions: Coronary Disease; Obesity
Intervention:
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified January 2010
Condition: Pregnancy
Intervention:
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified January 2010
Conditions: Amebiasis; Cryptosporidiosis; Giardiasis; Parasitic Disease; Parasitic Intestinal Disease
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Conditions: Growth Disorder; Mental Retardation; Multiple Abnormalies
Intervention:
Sponsor: National Human Genome Research Institute (NHGRI)
Recruiting - verified March 2009
Conditions: Amenorrhea; Hypoaldosteronism; Hypogonadism; Infertility; Premature Ovarian Failure
Intervention:
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified January 2010
Conditions: Psychotic Disorder; Schizoaffective Disorder; Schizophrenia
Intervention:
Sponsor: National Institute of Mental Health (NIMH)
Recruiting - verified June 2009
Condition: Healthy
Intervention:
Sponsor: National Institutes of Health Clinical Center (CC)
Recruiting - verified February 2010
Conditions: Sjogren's Syndrome; Xerostomia
Intervention:
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR)
Recruiting - verified January 2009
Condition: Breast Cancer
Interventions: Drug: letrozole; Other: placebo
Sponsors: NCIC Clinical Trials Group; National Cancer Institute (NCI); North Central Cancer Treatment Group; International Breast Cancer Study Group; Eastern Cooperative Oncology Group; Southwest Oncology Group; Cancer and Leukemia Group B; European Organization for Research and Treatment of Cancer
Recruiting - verified June 2009
Conditions: Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
Interventions: Biological: anti-thymocyte globulin; Biological: therapeutic allogeneic lymphocytes; Drug: cyclophosphamide; Drug: cyclosporine; Drug: fludarabine phosphate; Procedure: peripheral blood stem cell transplantation
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified June 2009
All Locations ... United States » ... Maryland » ... Bethesda 
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
